S&P Keeps Buy on Univision

Plus: Analysts upgrade Novell, comment on Boston Scientific, Human Genome Sciences, EDS, and more

From Standard & Poor's Equity Research

To continue reading this article you must be a Bloomberg Professional Service Subscriber.